Most Recent
The Australian to claim truth defence in JLL execs’ cases, court told
The publisher of The Australian will bring a truth defence to defamation claims by two sacked executives of commercial real estate broker JLL who claim they were falsely accused of sexual harassment, a court has heard. 
Construction PRO
Meriton loses land valuation challenge for Sydney development
A court has upheld the $63.8 million valuation of an inner-Sydney high-rise, rejecting Meriton's argument that it should be reduced to $52 million because of its isolation from public transport.
Construction PRO
Builder’s ‘cute’ bid to dodge fire safety fixes at Canberra development rejected
Chase Builders can't avoid completing fire safety rectification works at the Manhattan on the Park apartment complex in Canberra by citing a 10-year limitations period after running down the clock with litigation, a tribunal has said.
Construction PRO
CBEM loses appeal in payment dispute over Dural development
A Sydney builder has lost its challenge to a $453,000 judgment for a developer, with an appeals court finding the construction company claimed payment for a greater amount of work than was done on a project in Dural. 
Construction PRO
HopgoodGanim moves to new digs in heart of Brisbane CBD
HopgoodGanim Lawyers will upgrade its headquarter office next month with its move to 360 Queen Street in the centre of Brisbane's commercial precinct. 
Construction PRO
Baker McKenzie nabs new project finance head from HSFK
Baker McKenzie has lured a Herbert Smith Freehills Kramer partner to head the firm's project finance team, specialising in infrastructure and power projects.
Momofuku appeals loss in trade mark dispute with instant noodle giant
Famed restaurant chain Momofuku has filed an appeal after losing its challenge to a trade mark of instant noodle giant Nissin Foods, a court has heard.
ATO appeals win for YTL Power in $948M dispute over ElectraNet sale
The tax commissioner is challenging last month's loss in a $948 million capital gains dispute with Malaysia's YTL Power.
Suit accuses Telix of breaching licence agreement for cancer drug Zircaix
German pharmaceutical company Heidelberg Pharma has filed a lawsuit against Australian drug maker Telix alleging breach of a licence agreement for its kidney cancer diagnostic drug Zircaix. 
Treasurer blocks Cosette’s $672M takeover of Mayne Pharma
Treasurer Jim Chalmers has blocked Cosette's $672 million takeover of Mayne Pharma on national interest grounds after the US drug maker threatened to close a critical drug facility in Adelaide.